|
RAB30 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.75049999995291E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.97289999787276E-08 |
| Normal-vs-Stage2 |
3.795600E-04 |
| Normal-vs-Stage3 |
6.483000E-03 |
| Normal-vs-Stage4 |
1.826060E-02 |
| Stage1-vs-Stage2 |
4.538200E-01 |
| Stage1-vs-Stage3 |
1.097980E-01 |
| Stage1-vs-Stage4 |
4.439200E-01 |
| Stage2-vs-Stage3 |
5.773800E-01 |
| Stage2-vs-Stage4 |
8.411400E-01 |
| Stage3-vs-Stage4 |
8.245400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.90570000002666E-06 |
| Normal-vs-AfricanAmerican |
1.993300E-04 |
| Normal-vs-Asian |
9.298600E-03 |
| Caucasian-vs-AfricanAmerican |
9.708800E-01 |
| Caucasian-vs-Asian |
8.358800E-01 |
| AfricanAmerican-vs-Asian |
8.091400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.99350003171617E-09 |
| Normal-vs-Female |
1.152600E-01 |
| Male-vs-Female |
2.539100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.938900E-03 |
| Normal-vs-Extreme_Weight |
2.08544292945589E-12 |
| Normal-vs-Obese |
7.811200E-04 |
| Normal-vs-Extreme_Obese |
6.08679999999362E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.295380E-01 |
| Normal_Weight-vs-Obese |
9.535400E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.455600E-01 |
| Extreme_Weight-vs-Obese |
2.558500E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.052400E-01 |
| Obese-vs-Extreme_Obese |
6.357900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.409000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.849850E-04 |
| Normal-vs-Age(61-80Yrs) |
9.35609999475062E-08 |
| Normal-vs-Age(81-100Yrs) |
3.2004000005692E-08 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.610380E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.029570E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.972000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.677800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.898200E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.024580E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.98052685362882E-12 |
| Normal-VS-Type2 PRCC |
6.375300E-04 |
| Normal-VS-KIRP CIMP |
3.963200E-01 |
| Normal-VS-Unclassified PRCC |
4.629200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.367800E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.689800E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
9.602200E-03 |
| Type2 PRCC-VS-KIRP CIMP |
6.963500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.531570E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.156200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.58529999975066E-07 |
| Normal-vs-N1 |
1.715180E-01 |
| Normal-vs-N2 |
2.058600E-01 |
| N0-vs-N1 |
1.233780E-01 |
| N0-vs-N2 |
4.123000E-01 |
| N1-vs-N2 |
8.739000E-01 |
|
|
